Identiv has expanded its ID-Safe portfolio of near field communication (NFC) tags, positioning the technology as a tool to address ongoing concerns around product authentication, tampering, and ...

Ahead of LogiPharma Europe 2026, Richard Harrop explains why packaging must be more patient-centric. In the second part of ...

Pharma importers sourcing finished products and ingredients from the EU, Japan, South Korea, and India may see meaningful ...

Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The centerpiece of the ...

“We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental ...

In the final part of his interview with Pharmaceutical Commerce, Anthony “TJ” Rizzo, chief commercial officer of Cold Chain ...

The number of approved advanced therapies may triple by 2030. The majority of health system survey respondents agreed (63%) ...

Fran Gregory, VP of Emerging Therapies at Cardinal Health, discusses key findings from the company's 2026 Advanced Therapy Report.

Annex 21 is sometimes viewed as a narrow regulatory annex, but its implications are much broader. It sits at the intersection ...

In the second part of his interview with Pharmaceutical Commerce, Roel van den Akker, Deals partner at PwC, discusses the ...